Table_1_Increased Mortality Trends in Patients With Chronic Non-communicable Diseases and Comorbid Hypertension in the United States, 2000–2019.DOCX by Feiyun Ouyang (8594790)

“…</p>Results<p>The hypertension-related DM, CRD, and CA mortality rates increased over the 20 years, of which the AAPCs were 2.0% (95% CI: 1.4%, 2.6%), 3.2% (95% CI: 2.8%, 3.6%), and 2.1% (95% CI: 1.6%, 2.6%), respectively. Moreover, despite decreasing between 2005 and 2015, the hypertension-related CVD mortality rate increased from 2015 to 2019 [APC: 1.3% (95% CI: 0.7%, 1.9%)]. …”

VO_2peak results. by Imane Salmam (21485704)

“…<div><p>Background</p><p>Since the emergence of COVID-19, millions worldwide have continued to experience persistent symptoms months after infection. …”

Evaluation of heavy metal accumulation and tolerance in oxalic acid-treated <i>Phragmites australis</i> wetlands for textile effluent remediation by Suliman Mohammed Suliman Alghanem (18854887)

“…The OA addition resulted in decreased EL contents in the root and shoot by 10%–19% and 13%–15%, MDA by 9%–14% and 9%–20%, and H₂O₂ by 14%–21% and 9%–17%, in comparison to the respective treatments without OA. …”

Feasibility of real-time <i>in vivo</i> ⁸⁹Zr-DFO-labeled CAR T-cell trafficking using PET imaging by Suk Hyun Lee (8259696)

“…No significant accumulation of labeled cells was identified in tumors. A similar pattern was observed in <i>ex vivo</i> biodistributions on day 7 (lung 3.0% ± 1.0%ID, liver 19.8% ± 2.2%ID, spleen 2.3% ± 1.7%ID). …”

Microbial composition of the rectal fecal samples collected from rats 10 days after MCAO/R treated with or without FMT using 16S rRNA gene sequencing analyses. by guang chen (6632402)

“…Compared with the MCAO/R model group, FMT appeared to have partially reversed the imbalance (Figure 3A).</p> <p>On the phylum level, we analyzed the components and found that the relative abundance of Proteobacteria (0.59 to 17.14%), <em>Verrucomicrobiota</em> (0.17 to 18.74%), <em>Actinobacteriota</em> (0.34 to 2.06%), Bacteroidota (0.19 to 1.16%) and <em>Desulfobacterota</em> (0.14 to 1.47%) were significantly increased after MCAO/R compared with those in the sham control rats, whilst the relative abundance of <em>Firmicutes</em> (98.51 to 59.40%) was significantly decreased in the MCAO/R group (Figure 3B). …”

Supplemental data of Glucocorticoid Dependent Mesenchymal Cell Differentiation is Required for Perinatal Lung Morphogenesis and Lung Function by Yan Xu (6655778)

“…Cells were pelleted, counted and 50,000 cells per sample prepared for ATAC-seq at a depth of ~1,000,000 reads per sample. …”

SEAwise report on the impact of socioeconomic effects of fisheries management adapted according to input from review workshops by Isabella Bitetto (20145735)

“…<p dir="ltr">The SEAwise project works to deliver a fully operational tool that will allow fishers, managers, and policy makers to easily apply Ecosystem Based Fisheries Management. …”

PDLB - Balance Sheet by Nguyen Linh (19516642)

“…</p><p><br></p><p dir="ltr">ECIP capital: PDLB received $225M of ECIP capital, and the regulators assigned them the lowest possible dividend (0.5%) on this capital for the first year of payments (announced in June). If we assume PDLB continues to pay 0.5% on this preferred and they have a cost of preferred equity of 10%, then we can calculate the value of this $225M liability as just $11M, with the rest a write-up to equity.…”

S1 Fig - by Jérémie Le Pen (18551533)

“…LY6E and PLSCR1 restrict virus–cell membrane fusion at the endosome through unknown mechanisms; see [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002767#pbio.3002767.ref019" target="_blank">19</a>,<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002767#pbio.3002767.ref121" target="_blank">121</a>] and this study. …”

Table5_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

DataSheet1_Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe.docx by Jane Robertson (352569)

“…ESAC-Net countries consumed more penicillins (J01C; 8.7 versus 6.3 DDD per 1000 inhabitants per day), more tetracyclines (J01A; 2.2 versus 1.2), less cephalosporins (J01D; 2.3 versus 3.8) and less quinolones (J01M; 1.7 versus 3.4) than WHO Europe AMC Network countries. …”

Table1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table5_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

DataSheet1_Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe.docx by Jane Robertson (352569)

“…ESAC-Net countries consumed more penicillins (J01C; 8.7 versus 6.3 DDD per 1000 inhabitants per day), more tetracyclines (J01A; 2.2 versus 1.2), less cephalosporins (J01D; 2.3 versus 3.8) and less quinolones (J01M; 1.7 versus 3.4) than WHO Europe AMC Network countries. …”

Image2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tif by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”